Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD

August 1, 2024 updated by: University Hospital, Ghent

Impaired Toilet Training, Lower Urinary Tract Symptoms and Bowel Dysfunction in Children With Developmental Coordination Disorder

This cross-sectional case-control study aimed to determine whether there is a significant difference in the prevalence of impaired toilet training, LUTS, and functional bowel problems among children diagnosed with DCD and typically developing children (TDC).

Study Overview

Study Type

Observational

Enrollment (Estimated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ghent, Belgium
        • Recruiting
        • University Hospital Ghent
        • Contact:
    • East Flanders
      • Ghent, East Flanders, Belgium, 9000
        • Recruiting
        • Ghent University Hospital/Ghent University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Children with developmental coordination disorder and grade- and gender matched typically developing children.

Description

Inclusion Criteria:

  • Diagnosed with DCD by a multidisciplinary team (DCD case group)
  • Children with a typical development, grade and gender matched with the DCD case group (TDC control group).

Exclusion Criteria:

  • A DCD-Q score indicative for DCD (TDC control group)
  • Presence of other developmental disorders, such as ASS, ADHD or intellectual disability (TDC control group)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
DCD case group
The case group consists of children with developmental coordination disorder.
Vancouver symptom score for dysfunctional elimination syndrome, Dutch version, validated by 't Hoen et al. 2016. The questionnaire is filled in by the parents of the child.
Other Names:
  • VSSDES
Validated Developmental Coordination Disorder Questionnaire, Dutch version includes assessment of motor functioning. The questionnaire is filled in by the parents of the child.
Other Names:
  • DCD-Q
  • CVO
Unvalidated, complementary questions concerning impaired toilettraining and comorbidities. Questions were based on ICCS standardisation guidelines (Austin et al., 2015). The questionnaire is filled in by the parents of the child.
TDC control group
The control group consists of typically developing children, grade and gender matched with the DCD case group.
Vancouver symptom score for dysfunctional elimination syndrome, Dutch version, validated by 't Hoen et al. 2016. The questionnaire is filled in by the parents of the child.
Other Names:
  • VSSDES
Validated Developmental Coordination Disorder Questionnaire, Dutch version includes assessment of motor functioning. The questionnaire is filled in by the parents of the child.
Other Names:
  • DCD-Q
  • CVO
Unvalidated, complementary questions concerning impaired toilettraining and comorbidities. Questions were based on ICCS standardisation guidelines (Austin et al., 2015). The questionnaire is filled in by the parents of the child.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impaired toilet training
Time Frame: through study completion, 25 minutes
Prevalence of impaired toilet training in children with DCD compared to TDC
through study completion, 25 minutes
Daytime incontinence
Time Frame: through study completion, 25 minutes
Prevalence of daytime incontinence at 5 years old in children with DCD compared to TDC
through study completion, 25 minutes
Enuresis
Time Frame: through study completion, 25 minutes
Prevalence of enuresis at 5 years old in children with DCD compared to TDC
through study completion, 25 minutes
Fecal incontinence
Time Frame: through study completion, 25 minutes
Prevalence of fecal incontinence at 4 years old in children with DCD compared to TDC
through study completion, 25 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Toilet training difficulties
Time Frame: through study completion, 25 minutes
Prevalence and amount of toilet training difficulties in children with DCD compared to TDC
through study completion, 25 minutes
General bladder and bowel dysfunction
Time Frame: through study completion, 25 minutes
Prevalence of LUTS, bowel problems or combined bladder and bowel dysfunction in children with DCD compared to TDC
through study completion, 25 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ellen Vandamme, MD, University Hospital, Ghent
  • Principal Investigator: Bieke Samijn, PhD, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2023

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

March 7, 2024

First Submitted That Met QC Criteria

March 7, 2024

First Posted (Actual)

March 15, 2024

Study Record Updates

Last Update Posted (Actual)

August 2, 2024

Last Update Submitted That Met QC Criteria

August 1, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Urinary Tract Symptoms

Clinical Trials on Vancouver symptom score for dysfunctional elimination symptoms Questionnaire

Subscribe